Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-11
2008-03-11
Shemeem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S225000, C548S229000, C514S374000
Reexamination Certificate
active
10527127
ABSTRACT:
In particular, zolmitriptan or a pharmaceutically acceptable salt thereof, which includes a) Preparation of the diazonium salt of the aniline hydrochloride (II); followed by reduction and acidification to give hydrazine (III); b) In situ Reaction of the hydrazine hydrochloride (III) with α-keto-δ-valerolactone, to give the hydrazone (IV); c) Fischer indole synthesis of the hydrazone (IV), to give the pyranoindolone of formula (V); d) Transesterification of the pyranoindolone (V) to provide the compound (VI), in which R means a straight or branched C1-C4 alkyl; e) Conversion of the hydroxyl group of the compound (VI) into dimethylamino to give the indolecarboxylate (VII), in which R means a straight or branched C1-C4 alkyl; f) Saponification of the 2-carboalkoxy group of the compound (VII), to provide indolecarboxylic acid (VIII); g) Decarboxylation of the indolecarboxylic acid (VIII), to provide zolmitriptan and, eventually, to provide a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 9118897 (1991-12-01), None
patent: 9706162 (1997-02-01), None
Armengol Asparo Montserrat
Barjoan Pere Dalmases
Inke, S.A.
Shemeem Golam M. M.
Wolf Block Schorr & Solis-Cohen LLP
LandOfFree
Process for preparing zolmitriptan compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing zolmitriptan compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing zolmitriptan compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3942096